1. Home
  2. EW vs MET Comparison

EW vs MET Comparison

Compare EW & MET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

SELL

Current Price

$106.66

Market Cap

61.6B

Sector

Health Care

ML Signal

SELL

Logo MetLife Inc.

MET

MetLife Inc.

SELL

Current Price

$100.84

Market Cap

65.4B

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
EW
MET
Founded
1958
1863
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Life Insurance
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
61.6B
65.4B
IPO Year
1999
1999

Fundamental Metrics

Financial Performance
Metric
EW
MET
Price
$106.66
$100.84
Analyst Decision
Buy
Buy
Analyst Count
30
18
Target Price
★ $113.39
$111.13
AVG Volume (30 Days)
★ 4.4M
2.8M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
★ 2.31%
EPS Growth
N/A
★ N/A
EPS
1.61
★ 6.48
Revenue
$6,067,600,000.00
★ $77,084,000,000.00
Revenue This Year
$12.23
$3.08
Revenue Next Year
$9.84
$4.51
P/E Ratio
$66.63
★ $15.79
Revenue Growth
★ 11.55
8.59
52 Week Low
$74.66
$67.33
52 Week High
$107.69
$106.72

Technical Indicators

Market Signals
Indicator
EW
MET
Relative Strength Index (RSI) 77.78 52.36
Support Level $82.21 $92.95
Resistance Level N/A $103.65
Average True Range (ATR) 3.38 2.38
MACD 1.06 -0.03
Stochastic Oscillator 93.83 38.26

Price Performance

Historical Comparison
EW
MET

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

About MET MetLife Inc.

MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: group benefits, retirement and income solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Investment Managenent. Group Benefits and RIS are US-based, contributing to around 52% of the firm's 2025 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 14% of 2024 earnings. The EMEA and investment management segments contributed around 6% and 3% of 2025 earnings, respectively.

Share on Social Networks: